AVEO Pharmaceuticals (AVEO) Financials

$15.00

$0.00 (0.00%)

As on 20-Jan-2023 09:30EDT

Market cap

$521 Mln

Revenue (TTM)

$68 Mln

P/E Ratio

--

P/B Ratio

18

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	68.17	38.87	6.02	28.80	5.41	7.58
Cost of Revenue	11.50	4.74	--	17.96	20.65	25.18
Gross Profit	56.67	34.14	4.77	28.80	5.41	7.58
Operating Expenses	107.32	87.11	44.90	29.17	31.43	34.32
Operating Profit (EBIT)	-24.49	-49.55	-38.88	-0.37	-25.36	-28.81
Other Income	0.06	0.26	4.90	11.58	22.22	-33.74
Profit before Tax	-29.04	-53.34	-35.58	9.39	-5.33	-64.92
Provision for Tax	--	--	--	--	--	0.10
Profit after Tax (Net Income)	-29.04	-53.34	-35.58	9.39	-5.33	-65.03
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-29.04	-53.34	-35.58	9.39	-5.33	-65.03

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	28.85	45.87	35.29	14.85	-27.23	-40.76
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	29.97	40.74	14.67	14.64	37.05	58.84
Current Liabilities	42.42	18.73	16.95	21.12	18.12	32.12
Total Liabilities	143.66	105.34	66.91	50.60	27.94	50.20

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	0.50	0.61	1.40	--	--	0.02
Current Assets	100.73	104.74	65.51	50.60	27.94	50.18
Total Assets	132.16	105.34	66.91	50.60	27.94	50.20
Total Debt*	38.68	--	14.14	15.77	19.03	37.05
Net Current Assets	69.80	86.01	48.56	29.48	9.82	18.06

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-57.26	-37.98	-2.92	-25.03	-19.16
Cash Flow from Investing Activities	--	-16.87	17.70	-17.92	18.58	-10.40
Cash from Financing Activities	--	82.90	52.26	26.19	15.93	29.42
Net Cash Inflow / Outflow	--	8.78	31.98	5.36	9.48	-0.15

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	-0.85	-1.62	-1.69	0.63	-0.41	-5.91
Cash EPS ($)	--	-1.61	-1.69	0.63	-0.41	-5.91
Adjusted Book Value ($)	--	1.39	1.68	0.99	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.74	-1.81	-0.19	-1.93	-1.74
Free Cash Flow per Share ($)	--	-1.74	-1.83	-0.19	-1.93	-1.74

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-111.94	-88.91	83.75	89.53	-1,553.76
ROE (%)	-88.28	-131.44	-141.94	-151.65	15.68	304.67
ROA (%)	-22.03	-61.93	-60.56	23.91	-13.64	-167.84
EBIT Margin (%)	-35.93	-127.47	-564.53	32.60	-98.52	-856.63
Net Margin (%)	-42.56	-136.32	-325.95	23.25	-19.29	248.56
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	166.96	5.46	-0.79	4.32	-0.29	2.01
EBIT Growth (%)	54.79	-45.84	-461.94	276.17	91.79	-161.40
Net Profit Growth (%)	49.58	-49.90	-479.04	276.17	91.80	-141.85
EPS Growth (%)	58.94	0.05	-3.71	2.53	0.93	-0.54
Book Value Growth (%)	-45.31	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	-2.90	-3.41	1.00	-3.90	-0.47
Price / Book Value	17.96	3.37	3.43	0.63	-0.76	-0.75
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-19.67	-1.18	-2.17	-2.02	-4.91	-0.55
Close Price ($)	8.23	4.69	5.77	6.24	16.00	27.90
High Price ($)	9.37	18.24	10.71	21.40	35.90	42.40
Low Price ($)	3.06	4.67	2.23	4.69	14.00	4.99
Market Cap ($ Cr)	521.45	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	1.34	--	0.40	1.06	-0.70	-0.91
Short term debt to equity ratio	0.40	0.00	0.04	0.64	-0.12	-0.45
Current Ratio	2.37	5.59	3.87	2.40	1.54	1.56
Quick Ratio	2.35	5.50	--	--	--	1.56
Interest Coverage	-1.80	-12.25	-21.17	5.17	-2.43	-27.36

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	28.99	25.24	19.89	5.66	55.94	5.30
Asset Turnover	0.52	0.45	0.10	0.73	0.14	0.20
Receivable days	--	51.71	85.81	29.54	115.74	34.43
Inventory Days	--	127.69	--	--	--	--
Payable days	--	234.86	--	50.49	52.48	33.52
Cash Conversion Cycle	--	-55.46	--	--	63.26	0.91

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.